# Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma

> **NCT00895622** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 244 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **RADIATION:** 54 Gy radiotherapy
- **RADIATION:** 60 Gy radiotherapy

## Key facts

- **NCT ID:** NCT00895622
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2016-09
- **Final completion:** 2023-08-15
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2023-09-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895622, "Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00895622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*